Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors

Zhou, YT; Li, HY

Li, HY (通讯作者)，Xuanwu Hosp, Gen Surg Dept, Beijing, Peoples R China.

FRONTIERS IN NEUROSCIENCE, 2023; 17 ():

Abstract

Immunotherapy is a promising method for cancer treatment. Among them, immune checkpoint inhibitors targeting PD-1/PD-L1 are increasingly used for cert......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索